LPTX
USDLeap Therapeutics Inc. Common Stock
$0.404-0.008 (-2.039%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.412
High
$0.424
Low
$0.400
Volume
0.26M
Company Fundamentals
Market Cap
22.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.61M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.222Current $0.404High $3.92
Related News
PR Newswire
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has ...
View more
PR Newswire
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
USA News Group News Commentary – Major pharmaceutical companies are unveiling breakthrough cancer data at the European Society for Medical Oncology...
View more
Related Stocks
CLNE
Clean Energy Fuels Corp.
NASDAQ
Natural Gas Dis...
NUW
Nuveen AMT-Free Municipal Value Fund
NASDAQ
Investment Mana...
FMN
Federated Hermes Premier Municipal Income Fund
NASDAQ
Investment Mana...
RVYL
Ryvyl Inc.
NASDAQ
Professional Se...
FGB
First Trust Specialty Finance and Financial Opportunities Fund
NASDAQ
Finance/Investo...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.